Akums Drugs and Pharmaceuticals Q2 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
489.55
-0.25 (-0.05%)
-0.25 (-0.05%)Volume12.72 K
Updated: Wed 18 Feb, 2026 | 12:26:34
NSE
489.25-0.70 (-0.14%)
-0.70 (-0.14%)Volume3.23 L
Updated: Wed 18 Feb, 2026 | 12:14:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 960.92 | 931.98 | 3.10% | 1,958.27 | 1.89% |
| Depreciation/ Amortization | 37.86 | 36.92 | 2.56% | 60.14 | 8.60% |
| Operating Income | 56.61 | 92.05 | -38.50% | 192.87 | -37.11% |
| Net Income | 40.78 | 63.48 | -35.75% | -,156.42 | -37.46% |
| Other Operating Expenses Total | 141.22 | 137.00 | 3.08% | 29.09 | 3.96% |
| Net Income Before Taxes | 65.67 | 95.65 | -31.34% | -71.67 | -28.29% |
| Total Revenue | 1,017.53 | 1,024.03 | -0.63% | 2,151.14 | -1.51% |
| Selling/ General/ Admin Expenses Total | 189.27 | 176.14 | 7.45% | 445.60 | 5.09% |
| Diluted Normalized EPS | 2.66 | 4.15 | -35.90% | -8.82 | -36.51% |